The results of this study demonstrated that downregulation of activated EGFR, in the NCI-H1975 lung cancer cell line, did not, in fact, correlate with upregulation of RBM5, suggesting that RBM5 functions upstream of EGFR. This evidence concerns the gene RBM5 and lung carcinoma.